The public-private interface in the oncology market
How public science transforms drug-development efforts
Understanding how public science helps practitioners and policy-makers target scarce resources is key to improving the efficiency of drug discovery and development. This project studies how public science can promote innovation in the private-sector development of drugs and biologics, focusing on the oncology market. The aim is to identify the social challenges associated with diseases that are leading causes of deaths across the world; particularly in developing countries, where millions of people fail to fulfil their potential due to lack of access to effective drugs.